Fig. 2
From: In silico optimization of RNA–protein interactions for CRISPR-Cas13-based antimicrobials
In silico docking of crRNAs with Cas13 proteins to assess the RNA–protein interactions. This study is divided into two parts: the validation study to optimize the in silico docking of crRNAs and Cas13 proteins, and the candidate study to apply the optimized pipeline of in silico docking to test a list of candidate crRNAs on each Cas13 protein for RNA–protein interactions, as a preliminary step prior to experimental validation